Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat w momencie wyrażenia zgody na udział
- •Pisemna zgoda na udział w badaniu
- •Potwierdzona diagnoza raka płuc małokomórkowego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (3)
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, United States
Roudebush VA Medical Center
Indianapolis, United States
Sidney and Lois Eskenazi Hospital
Indianapolis, United States
Trial contact
Gabby Kline, BA
Shadia I. Jalal, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.